Guardant Health, Inc. 8-K

What Happened

• On January 11, 2026, Guardant Health, Inc. announced certain preliminary unaudited financial information for the quarter and full year ended December 31, 2025 via a press release (furnished as Exhibit 99.1 to the Form 8‑K).
• The company also disclosed it will post the presentation it will deliver at the 2026 J.P. Morgan Healthcare Conference to its website on January 12, 2026 (Investors > Events & Presentations).
• The filing notes the press release and presentation are being furnished under Regulation FD and are not being “filed” for purposes of Section 18 of the Exchange Act.

Key Details

• Press release date: January 11, 2026 (Exhibit 99.1).
• Period covered: quarter and fiscal year ended December 31, 2025.
• Presentation posting date: January 12, 2026 on GuardantHealth.com (Events & Presentations under Investors).
• Disclosure status: information furnished under Regulation FD (not “filed” under the Exchange Act).

Why It Matters

• This provides investors an early, unaudited view of Guardant’s recent quarterly and full‑year operating and financial performance ahead of formal audited filings and any conference presentation Q&A.
• The J.P. Morgan presentation may add context to the preliminary results and management’s outlook; both items can affect short‑term market expectations for earnings and revenue.
• Because the figures are preliminary and unaudited, investors should wait for the company’s subsequent SEC filings (e.g., Form 10‑K or earnings release) for final audited results.